4/A: Alumis Inc. Director Akkaraju Corrects Form 4 Filing to Include IPO Share Purchase

Srinivas Akkaraju, a director at Alumis Inc., filed an amended Form 4 to include the purchase of shares by Samsara BioCapital, L.P. in the company's initial public offering.

Summary

• Srinivas Akkaraju, a director of Alumis Inc., filed an amended Form 4 with the SEC.
• The amendment corrects an omission in the original filing regarding the purchase of shares by Samsara BioCapital, L.P. in Alumis Inc.'s initial public offering.
• On July 1, 2024, Samsara BioCapital, L.P. acquired 1,562,500 shares of common stock at a price of $16 per share.
• Following the transaction, the total number of shares beneficially owned indirectly by Akkaraju through Samsara BioCapital, L.P. is 3,266,498.
• Akkaraju disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a previous omission. It doesn't contain any particularly positive or negative news, but the correction itself is a positive sign of compliance.

Management Comments

• The Reporting Person disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.

Stakeholder Impact

• The correction of the Form 4 filing ensures transparency for shareholders regarding insider ownership.

Key Dates